Panel Discussion: Overcoming Challenges in Developing Dual-Payload ADCs for Enhanced Therapeutic Efficacy
Time: 5:00 pm
day: Scientific Program Day Two PM
Details:
- Exploring the potential advantages of dual-payload ADCs over conventional single-payload ADCs, particularly in overcoming secondary drug resistance
- Discussing strategies for selecting and optimizing payloads to achieve a balanced therapeutic profile, considering different mechanisms of action and toxicity profiles
- Highlighting preclinical data requirements to validate dual-payload ADCs, emphasizing the need for compelling evidence to support their clinical potential
